Osteogenic effects of antihypertensive drug benidipine on mouse MC3T3-E1 cells in vitro
- 13 May 2021
- journal article
- research article
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 22 (5), 410-420
- https://doi.org/10.1631/jzus.b2000628
Abstract
Hypertension is a prevalent systemic disease in the elderly, who can suffer from several pathological skeletal conditions simultaneously, including osteoporosis. Benidipine (BD), which is widely used to treat hypertension, has been proved to have a beneficial effect on bone metabolism. In order to confirm the osteogenic effects of BD, we investigated its osteogenic function using mouse MC3T3-E1 preosteoblast cells in vitro. The proliferative ability of MC3T3-E1 cells was significantly associated with the concentration of BD, as measured by methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay and cell cycle assay. With BD treatment, the osteogenic differentiation and maturation of MC3T3-E1 cells were increased, as established by the alkaline phosphatase (ALP) activity test, matrix mineralized nodules formation, osteogenic genetic test, and protein expression analyses. Moreover, our data showed that the BMP2/Smad pathway could be the partial mechanism for the promotion of osteogenesis by BD, while BD might suppress the possible function of osteoclasts through the OPG/RANKL/RANK (receptor activator of nuclear factor- κB (NF-κB)) pathway. The hypothesis that BD bears a considerable potential in further research on its dual therapeutic effect on hypertensive patients with poor skeletal conditions was proved within the limitations of the present study.Keywords
Funding Information
- National Natural Science Foundation of China (81600909, 81800934)
- the Zhejiang Provincial Medical Science and Technology Project of China (2017RC009and 2021KY773, 2018RC012, 2021KY773)
This publication has 41 references indexed in Scilit:
- Estimation and projection about the standardized prevalence of osteoporosis in mainland ChinaArchives of Osteoporosis, 2019
- Novel insights into cell cycle regulation of cell fate determinationJournal of Zhejiang University-SCIENCE B, 2019
- Epidemiological and clinical study of hip fracture in hospitalized elderly patients in Shanghai, ChinaArchives of Osteoporosis, 2019
- Osteoblast–osteoclast interactionsConnective Tissue Research, 2017
- Prevalence of osteoporosis in China: a meta-analysis and systematic reviewBMC Public Health, 2016
- Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosisEndocrine, 2014
- The BMP signaling and in vivo bone formationGene, 2005
- Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcriptionJournal of Cellular Physiology, 2004
- Osteoclast differentiation and activationNature, 2003
- A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic developmentJournal of Bone and Joint Surgery, 1999